We are live on ! Find out more
JUNS icon

Jupiter Neurosciences

9 hedge funds and large institutions have $2.39M invested in Jupiter Neurosciences in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,600% more capital inflows, than outflows

Capital inflows: $2.04M | Capital outflows: $75.5K

350% more funds holding

Funds holding: 2 → 9 (+7)

3.71% more ownership

Funds ownership: 0.2% → 3.9% (+3.7%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
9
Holders Change
+7
Holders Change %
+350%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

JUNS Hedge Fund Activity: Q3 2025 in Review

9 of the 7,665 institutional investors tracked by Wall St. Rank reported a position in Jupiter Neurosciences (JUNS) for Q3 2025, worth a combined $2.39M — up 3,508% from $66.3K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new JUNS positions and 0 closed out — a net gain of 7 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Vestor Capital, opening a new position worth an estimated $1.47M. The largest seller was UBS Group, cutting an estimated $75.5K.

  • 9 institutional investors held Jupiter Neurosciences (JUNS) as of Q3 2025, up from 2 in Q2 2025.
  • Funds reported $2.39M of Jupiter Neurosciences stock for Q3 2025, up 3,508% quarter-over-quarter.
  • 7 funds opened new Jupiter Neurosciences positions in Q3 2025 and 0 closed out, a net change of +7 holders.
  • The largest Jupiter Neurosciences buyer in Q3 2025 was Vestor Capital, an estimated $1.47M added.
  • The largest Jupiter Neurosciences seller in Q3 2025 was UBS Group, an estimated $75.5K sold.

Based on aggregated 13F filings for Q3 2025.